Elevation of B-type natriuretic peptide level in asymptomatic hepatitis b virus-positive patients is not associated with abnormalities of cardiac function

Medical Principles and Practice

Volumn 21, Issue 2, 2012, Pages 150-155

  Kucukazman, Metin ^a   Ata, Naim ^a   Yavuz, Bunyamin ^b   Dal, Kursat ^a   Ertugrul, Derun Taner ^a   Yalcin, Ahmet Arif ^b   Deveci, Onur Sinan ^b   Sen, Omer ^b   Akin, Kadir Okhan ^c   Cizmeci, Zeynep ^d   Sacikara, Muhammed ^a   Nazligul, Yasar ^a  

^a Kecioren Teaching and Research Hospital   (Turkey)

^b Kecioren Teaching and Research Hospital   (Turkey)

^c Kecioren Teaching and Research Hospital   (Turkey)

^d Departments of Microbiology   (Turkey)

Author keywords

B type natriuretic peptide; Hepatitis B virus; High sensitivity C reactive protein; Inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASYMPTOMATIC DISEASE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADULT; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DISEASES; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN;

EID: 84857361007     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000332440     Document Type: Article

References (22)

1. Han SH: Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004; 8: 403-418.
2. Irshad M, Dube R, Joshi YK: Impact of viral hepatitis on apo-and lipoprotein status in blood. Med Princ Pract 2007; 16: 310-314. (Pubitemid 46854779)
3. Hasan F, al-Khaldi J, Asker H, Varghese R, Siddique I, al-Shammali M, et al: Treatment of chronic hepatitis B with the sequential administration of interferon and lamivudine. Hepatogastroenterology 2003; 50: 2040-2042. (Pubitemid 37467990)
4. Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD: Hepatitis B virus infection and coronary atherosclerosis: Results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 2005; 11: 1292-1296.
5. Amirzadegan A, Davoodi G, Boroumand MA, Darabyan S, Dehkordi MR, Goodarzynejad H: Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J Med Sci 2007; 61: 648-655.
6. Moritani M, Adachi K, Arima N, Takashima T, Miyaoka Y, Niigaki M, Furuta K, Sato S, Kinoshita Y: A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J Gastroenterol 2005; 40: 1049-1053. (Pubitemid 43055289)
7. Dev BR, Philip L, John SJ: Brain natriuretic peptide: A selective centrally mediated vasodepressor in spontaneously hypertensive rats. Med Princ Pract 1996; 5: 129-136. (Pubitemid 126509675)
8. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832. (Pubitemid 28237306)
9. Collinson PO, Gaze DC: Biomarkers of cardiovascular damage. Med Princ Pract 2007; 16: 247-261. (Pubitemid 46854770)
10. Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L: Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation. J Cardiovasc Med (Hagerstown) 2009; 10: 671-676.
11. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS: Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601. (Pubitemid 34123434)
12. Karadag O, Calguneri M, Yavuz B, Atalar E, Akdogan A, Kalyoncu U, Kiraz S, Aksoyek S, Ozmen F, Ertenli AI: B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: What is the clinical significance? Clin Rheumatol 2007; 26: 1701-1704.
13. Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, et al: Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008; 133: 1088-1094. (Pubitemid 351685510)
14. Wu AH, Packer M, Smith A, Bijou R, Fink D, Mair J, Wallentin L, Johnston N, Feldcamp CS, Haverstick DM, Ahnadi CE, Grant A, Despres N, Bluestein B, Ghani F: Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: A multisite study. Clin Chem 2004; 50: 867-873. (Pubitemid 38543665)
15. Yavuz B, Sahiner L, Akdogan A, Abali G, Aytemir K, Tokgozoglu L, Kalyoncu U, Karadag O, Kiraz S, Ertenli I, et al: Left and right ventricular function is impaired in Behçet's disease. Echocardiography 2006; 23: 723-728. (Pubitemid 44450525)
16. Gedik M, Ozekinci T, Ozbek E, Atmaca S, Yilmaz S: Lack of correlation between CRP and hepatitis B viral load in serum of patients with chronic HBV. J Infect 2007; 54: 204. (Pubitemid 46075896)
17. Chen CJ, Yang HI, Iloeje UH, REVEALHBV Study Group: Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009; 49(5 suppl):S72-S84.
18. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Poewe W, et al: Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 2001; 103: 1064-1070. (Pubitemid 32200178)
19. Ishizaka N, Ishizaka Y, Takahashi E, Toda Ei E, Hashimoto H, Ohno M, Nagai R, Yamakado M: Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002; 105: 1028-1030. (Pubitemid 34212607)
20. Ma KK, Ogawa T, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004; 36: 505-513. (Pubitemid 38469941)
21. Moe GW: B-type natriuretic peptide in heart failure. Curr Opin Cardiol 2006; 21: 208-214. (Pubitemid 44315085)
22. Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, Omland T, Storrow AB, Krishnaswamy P, Abraham WT, et al: Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003; 41: 2010-2017. (Pubitemid 36677124)